Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Other Non-Current Liabilities: 2010-2018

Historic Other Non-Current Liabilities for EyePoint Pharmaceuticals (EYPT) over the last 4 years, with Jun 2018 value amounting to $19.8 million.

  • EyePoint Pharmaceuticals' Other Non-Current Liabilities fell 69.81% to $2.1 million in Q1 2019 from the same period last year, while for Mar 2019 it was $2.1 million, marking a year-over-year decrease of 69.81%. This contributed to the annual value of $19.8 million for FY2018, which is 38684.31% up from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Other Non-Current Liabilities of $19.8 million as of FY2018, which was up 38,684.31% from $51,000 recorded in FY2017.
  • EyePoint Pharmaceuticals' 5-year Other Non-Current Liabilities high stood at $19.8 million for FY2018, and its period low was $51,000 during FY2017.
  • In the last 2 years, EyePoint Pharmaceuticals' Other Non-Current Liabilities had a median value of $9.9 million in 2017 and averaged $9.9 million.
  • Data for EyePoint Pharmaceuticals' Other Non-Current Liabilities shows a peak YoY skyrocketed of 38,684.31% (in 2018) over the last 5 years.
  • EyePoint Pharmaceuticals' Other Non-Current Liabilities (Yearly) stood at $51,000 in 2017, then skyrocketed by 38,684.31% to $19.8 million in 2018.